Groups | Cohorts (n) | Patients (n) | Events (95%) | I 2 | Relative risk (95%) | p |
---|---|---|---|---|---|---|
Local control rate | ||||||
≧ 50 mm | ||||||
SABR | 1 | 102 | 0.716 (0.621–0.795) | 0.000 | 1 | – |
Particle | 1 | 24 | 0.875 (0.676–0.959) | 0.000 | 0.818 (0.674–0.994) | 0.043 |
< 50 mm | ||||||
RFA | 7 | 651 | 0.822 (0.730–0.888) | 16.549 | 1 | – |
MWA | 5 | 569 | 0.926 (0.866–0.960) | 0.000 | 0.888 (0.851–0.926) | < 0.001 |
SABR | 6 | 322 | 0.872 (0.787–0.927) | 32.839 | 0.943 (0.892–0.996) | 0.035 |
Particle | 2 | 94 | 0.909 (0.766–0.968) | 0.000 | 0.904 (0.840–0.973) | 0.007 |
≧ 30 mm | ||||||
RFA | 3 | 404 | 0.724 (0.524–0.862) | 7.164 | 1 | – |
SABR | 5 | 347 | 0.821 (0.698–0.901) | 25.909 | 0.882 (0.816–0.953) | 0.002 |
Particle | 3 | 118 | 0.899 (0.766–0.961) | 0.000 | 0.805 (0.739–0.877) | < 0.001 |
< 30 mm | ||||||
RFA | 4 | 247 | 0.888 (0.841–0.922) | 0.000 | 1 | – |
MWA | 4 | 510 | 0.907 (0.878–0.930) | 32.375 | 0.979 (0.929–1.032) | 0.427 |
SABR | 2 | 77 | 0.932 (0.846–0.971) | 0.000 | 0.953 (0.884–1.027) | 0.205 |
≧ 20 mm | ||||||
RFA | 5 | 468 | 0.773 (0.636–0.869) | 0.000 | 1 | – |
MWA | 3 | 412 | 0.914 (0.819–0.962) | 0.000 | 0.846 (0.799–0.896) | < 0.001 |
SABR | 7 | 424 | 0.851 (0.763–0.910) | 0.000 | 0.908 (0.853–0.968) | 0.003 |
Particle | 3 | 118 | 0.899 (0.775–0.959) | 31.931 | 0.860 (0.795–0.930) | < 0.001 |
< 20 mm | ||||||
RFA | 2 | 183 | 0.900 (0.847–0.936) | 0.000 | 1 | – |
MWA | 1 | 98 | 0.939 (0.870–0.972) | 0.000 | 0.958 (0.894–1.028) | 0.234 |